"To be fair, they've been pretty consistent with being unimpressed with the data so far, and MSB continues to refuse to generate new data, taking the easier route of reanalysing existing weak data."
Also, to be fair, not a smart move by SI, Krause and crew, especially when considering that at every opportunity since his appointment when addressing the media, conferences, etc, FDA Commissioner Califf has made it quite clear that for him it's primarily about the data. SI and Krause would have been aware of this, but... Has anything changed?, perhaps Pledge is right, it's time for a change of crew.
Anyway, who knows, MSB may get lucky.
Just sayin'.
Ann: Mesoblast Type A Meeting with FDA, page-572
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |